Endeavor Clinical Trials plays a key role in the success of Heron Therapeutics HTX-011 Compound. Results allude to a bright future in post-operative pain management. Click this link to find out more and hear Evolution Research Group’s Principal Investigator, Dr. Richard Pollak’s, take on the study.